Effects of obesity on the association between long-term sleep apnea treatment and changes in interleukin-6 levels: The Icelandic Sleep Apnea Cohort

Journal of Sleep Research

Volumn 24, Issue 2, 2015, Pages 148-159

  Arnardottir, Erna S ^a,b,c   Lim, Diane C ^c   Keenan, Brendan T ^c   Maislin, Greg ^c   Benediktsdottir, Bryndis ^b   Juliusson, Sigurdur ^a   Pack, Allan I ^c   Gislason, Thorarinn ^a,b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Continuous positive airway pressure; IL 6; Inflammation; Obesity; Obstructive sleep apnea; Soluble IL 6 receptor levels

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; BIOLOGICAL MARKER;

ADULT; AIRWAY PRESSURE; ARTICLE; BODY MASS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBESITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROPENSITY SCORE; SLEEP DISORDERED BREATHING; COMPLICATION; ICELAND; METABOLISM; MIDDLE AGED; PATIENT COMPLIANCE; SLEEP APNEA, OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA; UTILIZATION;

BIOMARKERS; BODY MASS INDEX; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; ICELAND; INTERLEUKIN-6; MALE; MIDDLE AGED; OBESITY; PATIENT COMPLIANCE; RECEPTORS, INTERLEUKIN-6; SLEEP APNEA, OBSTRUCTIVE;

EID: 84923810367     PISSN: 09621105     EISSN: 13652869     Source Type: Journal    
DOI: 10.1111/jsr.12252     Document Type: Article

References (45)

1. Ahmed, A., Husain, A., Love, T. E. et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur. Heart J., 2006, 27: 1431-1439.
2. Almendros, I., Farré, R., Planas, A. M. et al. Tissue oxygenation in brain, muscle, and fat in a rat model of sleep apnea: differential effect of obstructive apneas and intermittent hypoxia. Sleep, 2011, 34: 1127-1133.
3. Arnardottir, E. S., Mackiewicz, M., Gislason, T., Teff, K. L. and Pack, A. I. Molecular signatures in obstructive sleep apnea in adults: a review and perspective. Sleep, 2009, 32: 447-470.
4. Arnardottir, E. S., Maislin, G., Schwab, R. J. et al. The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort. Sleep, 2012, 35: 921-932.
5. Arnardottir, E. S., Janson, C., Bjornsdottir, E. et al. Nocturnal sweating-a common symptom of obstructive sleep apnoea: the Icelandic sleep apnoea cohort. BMJ Open, 2013, 3: e002795.
6. Baessler, A., Nadeem, R., Harvey, M. et al. Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers-a meta-analysis. J. Inflamm. (Lond.), 2013, 10: 13.
7. Bastard, J. P., Maachi, M., Lagathu, C. et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw., 2006, 17: 4-12.
8. Budhiraja, R., Parthasarathy, S., Drake, C. L. et al. Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep, 2007, 30: 320-324.
9. Campos-Rodriguez, F., Martinez-Garcia, M. A., De La Cruz-Moron, I., Almeida-Gonzalez, C., Catalan-Serra, P. and Montserrat, J. M. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann. Intern. Med., 2012, 156: 115-122.
10. Chirinos, J. A., Gurubhagavatula, I., Teff, K. et al. CPAP, weight loss, or both for obstructive sleep apnea. N. Engl. J. Med., 2014, 370: 2265-2275.
11. D'Agostino, R. B. Jr Propensity scores in cardiovascular research. Circulation, 2007, 115: 2340-2343.
12. Fain, J. N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm., 2006, 74: 443-447.
13. Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P. and Bahouth, S. W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology, 2004, 145: 2273-2282.
14. Fried, S. K., Bunkin, D. A. and Greenberg, A. S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab., 1998, 83: 847-850.
15. Goldstein, L. B., Bushnell, C. D., Adams, R. J. et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2011, 42: 517-584.
16. Hajer, G. R., Van Haeften, T. W. and Visseren, F. L. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart J., 2008, 29: 2959-2971.
17. Heymans, S., Hirsch, E., Anker, S. D. et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail., 2009, 11: 119-129.
18. Ikonomidis, I., Stamatelopoulos, K., Lekakis, J., Vamvakou, G. D. and Kremastinos, D. T. Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis, 2008, 199: 3-11.
19. Kim, S. Y., Choi, Y. J., Joung, S. M., Lee, B. H., Jung, Y. S. and Lee, J. Y. Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor. Immunology, 2010, 129: 516-524.
20. Kohler, M., Ayers, L., Pepperell, J. C. et al. Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax, 2009, 64: 67-73.
21. Kuna, S. T., Reboussin, D. M., Borradaile, K. E. et al. Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes. Sleep, 2013, 36: 641-649A.
22. Lieu, T. A., Au, D., Krishnan, J. A. et al. Comparative effectiveness research in lung diseases and sleep disorders: recommendations from the National Heart, Lung, and Blood Institute workshop. Am. J. Respir. Crit. Care Med., 2011, 184: 848-856.
23. Maislin, G. and Rubin, D. B. Design of non-randomized medical device trials based on sub-classification using propensity score quintiles, topic contributed session on medical devices. Proc. Joint Stat. Meet., 2010, 2182-2196.
24. Marin, J. M., Carrizo, S. J., Vicente, E. and Agusti, A. G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet, 2005, 365: 1046-1053.
25. McArdle, N., Devereux, G., Heidarnejad, H., Engleman, H. M., Mackay, T. W. and Douglas, N. J. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am. J. Respir. Crit. Care Med., 1999, 159: 1108-1114.
26. Mehra, R., Storfer-Isser, A., Kirchner, H. L. et al. Soluble interleukin 6 receptor: a novel marker of moderate to severe sleep-related breathing disorder. Arch. Intern. Med., 2006, 166: 1725-1731.
27. Mihara, M., Hashizume, M., Yoshida, H., Suzuki, M. and Shiina, M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin. Sci. (Lond.), 2012, 122: 143-159.
28. Naka, T., Nishimoto, N. and Kishimoto, T. The paradigm of IL-6: from basic science to medicine. Arthritis Res., 2002, 4(Suppl. 3): S233-S242.
29. Pack, A. I. and Gislason, T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog. Cardiovasc. Dis., 2009, 51: 434-451.
30. Pak, V. M., Keenan, B. T., Jackson, N. et al. Adhesion molecule increases in sleep apnea: beneficial effect of positive airway pressure and moderation by obesity. Int. J. Obes. (Lond.), 2014 (Epub ahead of print). doi: 10.1038/ijo.2014.123.
31. Peppard, P. E., Young, T., Palta, M., Dempsey, J. and Skatrud, J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA, 2000, 284: 3015-3021.
32. Platt, A. B., Kuna, S. T., Field, S. H. et al. Adherence to sleep apnea therapy and use of lipid-lowering drugs: a study of the healthy-user effect. Chest, 2010, 137: 102-108.
33. Reinke, C., Bevans-Fonti, S., Drager, L. F., Shin, M. K. and Polotsky, V. Y. Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes. J. Appl. Physiol., 2011, 111: 881-890.
34. Rosenbaum, P. and Rubin, D. B. The central role of the propensity score in observational studies for causal effects. Biometrika, 1983, 70: 41-44.
35. Rubin, D. B. Using Propensity scores to help design observational studies: application to the tobacco litigation. Health Serv. Outcomes Res. Methodol., 2001, 2: 169-188.
36. Sun, K., Halberg, N., Khan, M., Magalang, U. J. and Scherer, P. E. Selective inhibition of hypoxia-inducible factor 1α ameliorates adipose tissue dysfunction. Mol. Cell. Biol., 2013, 33: 904-917.
37. Trayhurn, P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol. Rev., 2013, 93: 1-21.
38. Trayhurn, P., Wang, B. and Wood, I. S. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br. J. Nutr., 2008, 100: 227-235.
39. Van Gaal, L. F., Mertens, I. L. and De Block, C. E. Mechanisms linking obesity with cardiovascular disease. Nature, 2006, 444: 875-880.
40. Villar, I., Izuel, M., Carrizo, S., Vicente, E. and Marin, J. M. Medication adherence and persistence in severe obstructive sleep apnea. Sleep, 2009, 32: 623-628.
41. Wang, B., Wood, I. S. and Trayhurn, P. Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch., 2007, 455: 479-492.
42. Weaver, T. E. and Grunstein, R. R. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc. Am. Thorac. Soc., 2008, 5: 173-178.
43. Weaver, T. E., Kribbs, N. B., Pack, A. I. et al. Night-to-night variability in CPAP use over the first three months of treatment. Sleep, 1997, 20: 278-283.
44. Xie, X., Pan, L., Ren, D., Du, C. and Guo, Y. Effects of continuous positive airway pressure therapy on systemic inflammation in obstructive sleep apnea: a meta-analysis. Sleep Med., 2013, 14: 1139-1150.
45. Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M. and Mohsenin, V. Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med., 2005, 353: 2034-2041.